Cheng et al. discovered that neuronal loss of CREST reduces the protein level of FUS, derepresses the transcriptional inhibition of chemokine genes which in turn causes microglial activation and proinflammation, and ultimately leads to axonal degeneration of motor neurons and impairment of locomotion.
INTRODUCTION
Ayotrophic lateral sclerosis (ALS) is one of the most severe neurodegenerative diseases characterized by the fast progressive degeneration of motor neurons in the central nervous system (CNS). Usually within 3-5 years of disease onset, patients suffer multiple symptoms including muscle atrophy, paralysis and respiratory failure, during which there are limited therapeutic approaches to alleviate disease symptoms. Moreover, clinical features of ALS appeared great heterogeneity, meaning that ALS patients may experience motor neuron death onset in different regions of CNS, such as the spinal cord, brainstem or motor cortex (Taylor et al., 2016) . ALS has heavy genetic components in which a series of genetic mutations have been identified. Since the ALS-causing mutations in the SOD1 gene were reported in 1993 (Rosen et al., 1993) , more than 50 ALS-associated genes have been subsequently reported, including the TARDBP, encoding TAR DNA-binding protein 43 (TDP43) (Sreedharan et al., 2008) , FUS (Kwiatkowski et al., 2009; Vance et al., 2009) , C9orf72 (DeJesus-Hernandez et al., 2011; Renton et al., 2011) . With the development of next-generation sequencing (NGS) technology, many previously unknown ALS-linked mutations have been certified via whole-exome sequencing.
Several de novo and inherited mutations in CREST have been recently reported in ALS patients via NGS-based whole-exome sequencing or target gene sequencing approaches (Chesi et al., 2013; Cirulli et al., 2015; Teyssou et al., 2014) , suggesting that CREST may be a potential ALScausing gene. Among all the mutations, we focus on one de novo missense mutation, CREST-Q388X, which leads to a truncation that lacks the nine amino acids in the C-terminus (Chesi et al., 2013) .
CREST is characterized as a calcium-regulated transcriptional activator of which C-terminus is responsible for gene activation through interacting to CREB-binding protein (CBP) (Aizawa et al., 2004) . Whereas the N-terminus of CREST protein has auto-inhibitory function via interacting with the chromatin remodeling BRG1 complex which in turn recruits histone deacetylase complex HDAC1 to inhibit gene transcription (Qiu and Ghosh, 2008) . Although previous study has shown that both loss of CREST and overexpression of Q394X (the corresponding truncation of mouse Crest homolog) or I123M mutant block the depolarizationinduced dendritic outgrowth in cultured neurons (Aizawa et al., 2004; Chesi et al., 2013) , whether mutations of CREST lead to ALS-like phenotypes in vivo remain to be determined. 4 Previous publications have demonstrated that non-neuron-involved chronic inflammatory responses play a critical role in the pathogenesis of ALS (Clement et al., 2003; Glass et al., 2010; Neymotin et al., 2009; Yamanaka et al., 2008) . During neuroinflammatory responses, microglial activation, astrogliosis and infiltration of peripheral immune cells are the main observable pathophysiological hallmarks (Alexianu et al., 2001; Beers et al., 2011; Engelhardt and Appel, 1990; Engelhardt et al., 1993; Hall et al., 1998; Kawamata et al., 1992; Mantovani et al., 2009; Turner et al., 2004) , and subsequent production of neurotoxic factors such as tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) can deteriorate disease progression (Meissner et al., 2010; Weydt et al., 2004) . As resident macrophages in CNS, microglia perform the first defense line of innate immune system, and thereby the excess activation of microglia predominantly conducts sustained neuroinflammatory responses that contribute to the progression of ALS or other neurodegenerative diseases (Boillee et al., 2006; Frakes et al., 2014; Mass et al., 2017) . Therefore, whether CREST may contribute to the neuroinflammation in vivo and mice carrying ALS-like CREST mutations may photocopy ALS-like phenotypes are yet to be determined.
In this study, we show the impaired protein stability of Q388X mutant compared to wild-type (WT) CREST in contrast to the previous report (Kukharsky et al., 2015) . Importantly, we demonstrate that microglial appearance exhibits activated morphology including the enlargement of cell bodies and the decreased complexity of processes in both CREST knockout (KO) mice and homozygous Crest Q394X/Q394X (Abbreviated as Q394X) mice, suggesting that CREST haploinsufficieny and ALS-related mutation leads to microglial activation and sustains the proinflammatory state in CNS. In agreement with ALS-like phenotypes, we also show the 5 denervation of tibialis anterior (TA) muscles in CREST KO mice and the locomotion impairment in both CREST KO and Q394X mice. Finally, we found the upregulation of two important chemokines, Cxcl10 and Ccl2, in neurons lack of CREST which may contribute to the activation of inflammation in CNS. Taken together, we demonstrate that neuronal loss of CREST function caused by the ALS-linked mutation induces the alteration of immune-related genes expression which leads to the microglial activation and sustained proinflammatory responses, which in turn impair motor neurons and motor behaviors of mutant mice.
RESULTS

The Q388X Mutation Decreases Protein Stability of CREST in vitro and in vivo
To study protein properties of the CREST-Q388X mutant, we constructed lentiviral vectors expressing cDNA of human WT CREST and Q388X mutant respectively, and infected lentivirus into primary cortical neurons isolated from embryonic C57BL/6 mice. Although there was no statistical difference between basal levels of CREST WT and Q388X mutant protein, we surprisingly found that the protein level of Q388X mutant was significantly reduced compared to WT if protein synthesis was blocked by chlorhexidine (CHX) treatment, suggesting that the protein stability of CREST-Q388X mutant is much lower compared to WT in cultured neurons in vitro ( Figures 1A and 1B ).
To further examine the role of CREST Q388X mutation in vivo, we constructed CREST knockout (KO) mice and the Q394X mice carrying point mutation Q394X in the Crest gene (the corresponding mutation of mouse CREST homolog for human CREST-Q388X) with the CRISPR/Cas9 technology ( Figures 1C and 1D ). Consistent with previous report, most of the 6 homozygous KO (Crest -/-) mice were lethal, and survivors were much smaller in size and had severe locomotion impairment compared to WT or heterozygous (Crest +/-) littermates ( Figure   1E ) (Aizawa et al., 2004 (Figures S1J, S1K, S1O and S1P).
We further performed immunohistochemistry analysis with Iba1 antibody in aged Crest
and WT mice at 6 months of age. Consistently, we observed morphological features of chronically activated microglia (increased soma area and decreased branch length or number) in both lumbar spinal cord and motor cortex in Crest +/-mice, but not in WT mice of the same age (Figures 2A-2J ). Interestingly, we noticed that the complexity of microglial branches did not change in cerebral motor cortex of Crest +/-mice at P14, but at 6 months, significant decreases in branch length and number were detected in the same region, suggesting that the extent of microglial activation increases in Crest +/-mice with age (Figures 2I, 2J, S1O and S1P). Taken together, we demonstrate that loss of CREST directly leads to microglial activation in the CNS of mice.
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Besides the morphological analysis of microglia, we tested expression levels of genes associated with the neurotoxic proinflammatory state in Crest +/-and WT mice. Interestingly, we found a 2-fold upregulation of proinflammatory gene cyclooxygenase-2 (Cox-2, also known as Ptgs2), but not IL-1β (Il1b) or TNF-α (Tnfa), in cortical tissue of Crest +/-mice at 18 months of age ( Figure 2K ). This result is consistent with the finding that increased expression of Cox-2 in ALS patients and SOD1 mouse model (Almer et al., 2001; McGeer and McGeer, 2002) .
Together, we demonstrate that loss of CREST results in both microglial activation and the onset of proinflammatory processes in CNS.
We further analyzed neurodegenerative phenotypes of both somatic and axonal morphology of motor neurons in lumbar spinal cord of Crest +/-mice and WT littermates at 6 months of age. cytoplasm may be toxic to neurons (Mackenzie et al., 2007; Neumann et al., 2006; Van Deerlin et al., 2008) . However, we did not find that the formation of YB1-positive stress granules under the treatment of sodium arsenite was influenced in isolated primary cortical neurons from embryonic CREST KO or WT littermates (Figures S2A and S2B) . To further illustrate the 9 dosage effects of CREST on axonal morphology, we transfected plasmids expressing short hairpin RNA (shRNA) of CREST (Qiu and Ghosh, 2008) or human WT CREST cDNA into mouse primary cultured neurons and detected the axonal phenotype by immunostaining with axonal marker SMI312. We found that neither knockdown nor overexpression of CREST in neurons affected the axonal length ( Figures S2C and S2D) . Thus, we suggest that the denervation of NMJs in Crest +/-mice may be caused by chronic microglial activation and proinflammatory responses, rather than CREST regulating axonal development directly.
Activation of Microglia Occurs in the CREST Q394X Mice
Next, we would like to determine whether inflammatory responses are also activated in the CNS of Q394X mutant mice. After immunohistochemical analysis of Iba1-positive microglia in cerebral motor cortex and lumbar spinal cord of Q394X mice and WT littermates, we showed significant increase in soma area and decrease in soma roundness but no alteration of branch complexity of microglia in lumbar spinal cord of Q394X mice at 6 months, compared to WT littermates ( Figures 3A-3E ). Moreover, there were increase of soma area and decrease of length and number of branches of microglia in motor cortex of Q394X mice compared to WT at 6 months ( Figures 3F-3J ). Therefore, we identified similar signs of increased inflammatory responses in motor cortex and lumbar spinal cord of Q394X mice, as they are in CREST haplosufficiency mice, suggesting that Q394X mice exhibits neuropathological symptoms in CNS. Figure 4A ). Moreover, Crest +/-mice fell more easily from the rotating rod than WT littermates in the fixed speed task of rotarod test ( Figure 4B ). In the beam walking test, Crest +/-mice showed significantly more slipped steps compared to WT mice ( Figure 4C , Videos S1 and S2), indicating that motor coordination abilities of Crest +/-mice are indeed compromised.
Both CREST KO and Q394X Mice Show the Impairment of Motor Phenotypes
We further examined the motor phenotypes of Q394X mice at 18 months of age. The general body weight and health of Q394X mice were also normal ( Figure S4A ). Although exhibiting no defects in open field and rotarod tests ( Figures S4B and S4C ), Q394X mice also showed more foot slips in the beam walking test compared to WT littermates ( Figure 4D , Videos S3 and S4), indicating similar impairment of motor phenotypes in Q394X mice as in Crest +/-mice. Taken together, we demonstrate that both haploinsufficiency and Q394X mutation of CREST can lead to elevated inflammatory responses in CNS and deficits in motor coordination in vivo.
The CREST-BRG1 Complex Suppresses Expression of Cytokine Genes Ccl2 and Cxcl10
via Histone Deacetylation in Neurons
Prior to the investigation of molecular mechanisms underlying the increase of inflammatory responses in CREST deficient mice, we sought to determine the expression pattern of CREST in 11 CNS. According to the data from Brain RNA-Seq database (Zhang et al., 2014) and previous report, CREST is highly expressed in neurons compared to other cell types in both human and mouse CNS ( Figure S5A ) (Aizawa et al., 2004) . We confirmed this conclusion by performing immunohistochemistry experiments with various antibodies in cerebral motor cortex and lumbar spinal cord of adult WT mice. In agreement with previous data, we found that CREST mostly was not expressed in Iba1-positive microglia either in motor cortex or lumbar spinal cord ( Figures S5B and S5C ). However, CREST showed some expression in GFAP-positive astrocytes in white matter of lumbar spinal cord but not in motor cortex of WT mice ( Figures S5B and   S5C ). Therefore, we suggest that neuronal loss of CREST may contribute to the microglial activation in CNS.
Given the fact that CREST is a critical transcriptional regulator (Qiu and Ghosh, 2008) , we examined gene expression profiles by performing microarray analysis in primary cortical neurons infected with lentivirus harboring shRNA targeting CREST or control shRNA (Figures 5A, S6A and S6B). Using DAVID bioinformatics resources online (https://david.ncifcrf.gov) (Huang et al., 2009a, b) , we performed gene ontology (GO) analysis of the microarray data and surprisingly found that the most significantly affected genes were predominantly associated with immune-associated processes ( Figure 5B ), suggesting the role of CREST in regulating the expression of genes related to inflammatory responses. Among the top 10 of the most remarkably upregulated genes, we selected two important chemokines, Ccl2 and Cxcl10, which have been reported to play critical roles in microglial activation and inflammatory response, for further analysis (Clarner et al., 2015; Selenica et al., 2013) . We first confirmed that mRNA levels of Ccl2 and Cxcl10 were significantly upregulated in CREST knockdown neurons compared to 12 control neurons with real-time PCR ( Figure 5C ). Moreover, we observed a significant decrease in mRNA level of Cxcl10 in CREST overexpressing neurons ( Figures S6C and S6D ). We then examined expression levels of endogenous Ccl2 and Cxcl10 in primary cortical neurons isolated from embryonic cortices of Crest -/-, Q394X and WT mice, respectively. Importantly, we found that mRNA levels of both Ccl2 and Cxcl10 were markedly higher in Crest -/-and Q394X neurons compared to WT littermates, respectively ( Figures 5D and 5E) . Thus, we demonstrate that neuronal loss of CREST leads to the altered expression of immune-related genes, such as the upregulation of chemokines Ccl2 and Cxcl10, which may contribute to the microglial activation and elevated inflammatory responses.
To further reveal the molecular mechanism underlying the regulation of Ccl2 and Cxcl10 in neurons by CREST, we hypothesized that CREST inhibited the transcription of these two genes through the BRG1-CREST complex recruiting the histone deacetylase such as HDAC1 (Qiu and Ghosh, 2008) . To test this hypothesis, we performed chromatin immunoprecipitation (ChIP) experiments in cultured neurons with anti-CREST and anti-HDAC1 antibodies. Indeed, we found that both CREST and HDAC1 interacted with the promoter regions of Ccl2 and Cxcl10 genes ( Figure 5F ). Moreover, mRNA levels of Ccl2 and Cxcl10 were increased in BRG1 knockdown cortical neurons by shRNA transfection ( Figures S6E and S6F ) compared to control neurons ( Figure 5G ). Consistently, we detected significantly upregulated mRNA levels of Ccl2
and Cxcl10 in neurons treated with an HDAC inhibitor trichostatin A (TSA) compared to controls ( Figure 5G ). Taken together, we suggest that the CREST-BRG1 complex plays a critical role in inhibiting the transcription of Ccl2 and Cxcl10 in neurons via HDAC-dependent histone deacetylation.
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Decreased Protein Level of FUS in the CNS of CREST KO Mice
Besides the regulation of immune-related genes by CREST in neurons, we also wonder whether CREST can influence the expression of other important ALS-linked genes, such as FUS which has been reported as a CREST-binding protein (Chesi et al., 2013) Figures 6C and 6D ). These data suggest that FUS appears to be loss-of-function in CREST mutant mice, further suggesting a converged pathway for ALS pathogenesis from different genetic causes.
DISCUSSION
Numerous publications have illustrated that chronic proinflammatory responses contribute to the pathogenic mechanisms underlying the progression of neurodegenerative diseases. In this study, we reveal that microglial appearance exhibits activation morphology including the enlargement of cell bodies and the decreased complexity of branches in both CREST KO and Q394X mutant mice. Since the differentiated subsets of activated microglia, including proinflammatory (M1) and antiinflammatory (M2) microglia (Kigerl et al., 2009) , we detected the expression of some inflammatory genes in Crest +/-mice and WT littermates at 18 months and found a specific 14 upregulation of proinflammatory gene Cox-2, suggesting the overall effects of CREST haploinsufficiency on the chronic activation of neurotoxic M1 microglia, which may cause the axonal degeneration of motor neurons in the spinal cords. Although the increased expression of Cox-2 in ALS patients and SOD1 mutant mice has been reported (Almer et al., 2001) , one more interesting discovery is that the expression of Cox-2 is specifically increased in ALS patients rather than other neurodegenerative disease cases (McGeer and McGeer, 2002) . Moreover, inhibition of the enzymatic activity of COX-2 may delay the disease onset and ameliorate the survival of ALS mice (Drachman et al., 2002; Pompl et al., 2003) , suggesting that chronic activation of M1 microglia and concomitant upregulation of Cox-2 caused by loss of CREST contribute to ALS pathogenesis.
Consistent with axonal degeneration in CREST haploinsufficiency mice, we found that both
Crest +/-and Q394X mice exhibited deficits in motor coordination tasks, further confirming the connection between CREST and ALS pathogenesis. However, we did not detect very serious neurodegenerative phenotypes as in SOD1 mutant transgenic mice. Considering the involvement of both genetic and environmental factors in the pathogenesis of ALS, we may try some artificial manipulations, such as the administration of lipopolysaccharide (LPS), in CREST KO or mutant mice to induce more significant inflammatory responses and anticipate the appearance of more typical ALS symptoms (Nguyen et al., 2004) .
We provide evidence to illustrate the alteration of immune-related genes, such as the upregulation of chemokines Cxcl10 and Ccl2, in CREST deficient or ALS-related mutation Q388X-expressing neurons, which may play a critical role in microglial activation and increased proinflammatory responses in vivo. Moreover, we demonstrate that CREST may directly inhibit 15 the transcription of Cxcl10 and Ccl2 genes through the CREST-BRG1-HDAC1 complex interacting with the promoter regions (Qiu and Ghosh, 2008) . Consistent with the notion that upregulation of chemokines in CNS may contribute to the infiltration of periphery immune cells, increased expression of Ccl2 in SOD1 mutant transgenic mice or ALS patients has been reported to induce the infiltration of dendritic cells and promote the acquisition of properties of antigenpresenting cells by microglia (Henkel et al., 2006; Henkel et al., 2004; Philips and Robberecht, 2011) , suggesting the involvement of T cell infiltration in microglial activation in CREST mutant mice.
Another interesting pathological phenotype we observed in CREST KO mice is the decreased protein level of FUS in CNS. Previous publications have shown that knockdown of FUS can reduce the cell viability in vitro, and cause the anatomical loss of neuromuscular junctions and concomitant impairment of locomotion ability in Drosophila and zebrafish models (Armstrong and Drapeau, 2013; Sasayama et al., 2012; Ward et al., 2014) , suggesting that besides the neurotoxic proinflammation induced by microglial activation, the loss of FUS may also contribute to the degeneration of motor neurons in CREST KO mice.
In conclusion, we demonstrate that CREST is a pathogenic gene for ALS, mutations of which lead to upregulation of chemokine genes in neurons, subsequently activate microglia, increase proinflammatory responses in vivo, and ultimately impair motor function in aged CREST KO and Q394X mutant mice. These data provide a transcriptional pathway for neuroinflammation activation in ALS, suggesting that approaches of modulating histone deacetylase complex may be the candidates for therapeutic intervenes.
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